Current Trends in Tort Reform and Pharmaceuticals Manufacturers’ Liability: Michigan’s Combination Product Exception

Pharmaceuticals Litigation Overview Pharmaceuticals litigation is usually expensive, lengthy, and sensitive. Over the past thirteen years, pharmaceutical companies have paid billions of dollars to settle U.S. federal lawsuits alone. In particular, litigation under products liability doctrine have accounted for the majority of settlements per dollar from January 2009 to May 2011, totaling $8.6 billion. Although many of these cases were brought by enforcement agencies such as the Department of Justice, class action lawsuits are increasingly Continue Reading →

STLR Link Round-Up – Oct. 17, 2014

San Francisco Leading the way in Regulating Airbnb Regulating Airbnb, the online, community-based home rental service, has been difficult. For example, Airbnb in New York has shown how the deregulated nature of that market leads to complaints from neighbors, springboards for illicit activity, and violations of local laws in subletting, zoning, and tax, even prompting action by New York Attorney General Eric Schneiderman. New York’s regulations in response to Airbnb may be too overreaching in Continue Reading →